Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the plasma fractionation market?
The growth of the plasma fractionation market has been robust in the past few years. The market’s size is set to climb from $31.42 billion in 2024 to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The previous growth can be tied to a rise in the cases of hemophilia and immunodeficiency disorders, a growing elderly population, a surge in demand for immunoglobulins, an extension in plasma collection centers, and an increase in surgical procedures.
What will be the plasma fractionation market size in the future?
The market for plasma fractionation is anticipated to witness a significant expansion in the coming years, escalating to a value of $51.56 billion in 2029 with a CAGR of 10.6%. The surge in growth during the projected period is due to factors such as increased global healthcare spending, the expanding use of plasma-derived medicine, a rise in research and development investment, the need for plasma in treating neurological conditions, and the broadening of plasma fractionation facilities. Key trends during this forecast period encompass the advancement of novel fractionation technologies, a shift towards therapies involving albumin and immunoglobulin, a growing demand for specialized plasma products, emphasis on pathogen inactivation technologies, and strategic alliances and partnerships within the plasma industry.
Get your plasma fractionation market report here!
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report
What main drivers are fueling expansion in the plasma fractionation market?
The plasma fractionation market is predicted to expand due to the escalating prevalence of chronic illnesses. Chronic diseases, such as heart disease, cancer, and diabetes, are identified as ailments that persist for a year or more and needs constant medical intervention. Utilizing plasma products to treat patients suffering from chronic illnesses effectively curtails morbidity, enhances the quality of life, and proves to be economically viable, which consequently stimulates the demand for plasma fractionation. For example, a report disseminated in January 2023 by the National Library of Medicine, an organization based in the US, anticipates the number of individuals aged 50 years and older with one or more chronic ailments to surge by 99.5%, escalating to 142.66 million by 2050 from 71.522 million in 2020, exclusively in the United States. Hence, the augmentation of chronic disease cases is fueling the growth of the healthcare analytical testing service market. Therefore, the priming prevalence of chronic diseases across all age groups is expected to drive the growth of the plasma fractionation market.
What key areas define the segmentation of the global plasma fractionation market?
The plasma fractionation market covered in this report is segmented –
1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes
Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp
Who are the dominant players expanding their reach in the plasma fractionation market?
Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP
How are evolving market trends shaping plasma fractionation Strategies?
Leading businesses in the sector are integrating novel technologies like advanced methodologies for processing donated human plasma into significant medications. These state-of-the-art technologies are aimed at increasing the efficiency and safety of the process. For instance, CSL Behring, a company based in Germany, established a new $470 million cutting-edge plasma fractionating facility in March 2023. The facility uses advanced technology to improve plasma processing efficiency and safety, which guarantees better quality and more dependable medicines. The facility aids in satisfying the increasing demand by augmenting the supply of these essential medications, ensuring that a greater number of patients receive potentially life-saving treatments. The risk of contamination is mitigated, and overall hygiene conditions are improved by the state-of-the-art automation and self-cleaning systems, thereby enhancing patient safety.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543
Which regions are emerging as leaders in the plasma fractionation market?
North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report
Porcine Plasma Feed Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report
Blood Transfusion Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
